Brazil GDP decline set for less than feared at 5.8 percent: IMF
President Donald Trump told social media followers to not be afraid of COVID-19, with detractors criticizing the statement as insensitive to those who lost loved ones in the pandemic.
Trump leaves hospital for White House -- removing mask immediately
Fresh ceasefire call as Karabakh conflict escalates
Kentucky Attorney General Daniel Cameron was ordered by a Louisville judge to respond to a grand juror's request to speak by Wednesday.
UK court asks for more clarity on Venezuela presidency recognition
Rep. Matt Gaetz compared President Trump to Chuck Norris in his ability to fight COVID-19.
ExxonMobil to cut European workforce 11% with 1,600 layoffs
China leads UN call for US to end 'coercive' sanctions
Pelosi, Mnuchin continue stimulus negotiations
Belarus opposition leader joins Berlin protest ahead of Merkel meeting
The annual interest rates on some retail credit cards are nearly 30%.
Minors are deported without process after being held for as long as 28 days. The deportations themselves are not banned.
Biden so far has tested negative for coronavirus and says he will debate Trump Oct. 15 as long as scientists say it is safe.
Public investment key to Covid-19 recovery: IMF
The U.S. Secret Service is considered among the world's elite. Security members stationed in Washington D.C. make more than their peers stationed elsewhere.
Tropical Storm Delta is forecast to push northwest toward the U.S. Gulf Coast, while Tropical Storm Gamma is expected to hover over southeastern Mexico
The J Balvin meal combo will be available at McDonald's through Nov. 1.
The closures will impact roughly 45,000 employees, though it is not clear who will remain employed and who will be released.
His denouncements included the Catholic Church and its own justification of war as a means of defense.
Kenzo Takada died on Oct. 4 from complications linked to coronavirus. He was 81. Takada left an estimated $100 million fortune at the time of his death.
The transaction is expected to lessen Bristol Myers Squibb’s dependence on cancer drugs for revenues.